Literature DB >> 14627872

Hallucinations associated with initiation of guanfacine.

Craig D Boreman, L Eugene Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14627872     DOI： 10.1097/00004583-200312000-00004

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  4 in total

Review 1.  Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.

Authors:  Lawrence Scahill
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 2.  Lifetime evolution of ADHD treatment.

Authors:  Federico Mucci; Barbara Carpita; Giovanni Pagni; Alessandra Della Vecchia; Sarah Bjedov; Andrea Pozza; Donatella Marazziti
Journal:  J Neural Transm (Vienna)       Date:  2021-05-15       Impact factor: 3.850

Review 3.  Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents.

Authors:  Nicholas T Bello
Journal:  Patient Prefer Adherence       Date:  2015-06-30       Impact factor: 2.711

4.  Once-daily treatment of ADHD with guanfacine: patient implications.

Authors:  Brandon C Strange
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.